25 research outputs found
A biophysical model of endocannabinoid-mediated short term depression in hippocampal inhibition
Memories are believed to be represented in the synaptic pathways of vastly interconnected networks of neurons. The
plasticity of synapses, that is, their strengthening and weakening depending on neuronal activity, is believed to be the basis
of learning and establishing memories. An increasing number of studies indicate that endocannabinoids have a widespread
action on brain function through modulation of synap–tic transmission and plasticity. Recent experimental studies have
characterised the role of endocannabinoids in mediating both short- and long-term synaptic plasticity in various brain
regions including the hippocampus, a brain region strongly associated with cognitive functions, such as learning and
memory. Here, we present a biophysically plausible model of cannabinoid retrograde signalling at the synaptic level and
investigate how this signalling mediates depolarisation induced suppression of inhibition (DSI), a prominent form of shortterm
synaptic depression in inhibitory transmission in hippocampus. The model successfully captures many of the key
characteristics of DSI in the hippocampus, as observed experimentally, with a minimal yet sufficient mathematical
description of the major signalling molecules and cascades involved. More specifically, this model serves as a framework to
test hypotheses on the factors determining the variability of DSI and investigate under which conditions it can be evoked.
The model reveals the frequency and duration bands in which the post-synaptic cell can be sufficiently stimulated to elicit
DSI. Moreover, the model provides key insights on how the state of the inhibitory cell modulates DSI according to its firing
rate and relative timing to the post-synaptic activation. Thus, it provides concrete suggestions to further investigate
experimentally how DSI modulates and is modulated by neuronal activity in the brain. Importantly, this model serves as a
stepping stone for future deciphering of the role of endocannabinoids in synaptic transmission as a feedback mechanism
both at synaptic and network level
Methamphetamine-Induced Dopamine-Independent Alterations in Striatal Gene Expression in the 6-Hydroxydopamine Hemiparkinsonian Rats
Unilateral injections of 6-hydroxydopamine into the medial forebrain bundle are used extensively as a model of Parkinson's disease. The present experiments sought to identify genes that were affected in the dopamine (DA)–denervated striatum after 6-hydroxydopamine-induced destruction of the nigrostriatal dopaminergic pathway in the rat. We also examined whether a single injection of methamphetamine (METH) (2.5 mg/kg) known to cause changes in gene expression in the normally DA-innervated striatum could still influence striatal gene expression in the absence of DA. Unilateral injections of 6-hydroxydopamine into the medial forebrain bundle resulted in METH-induced rotational behaviors ipsilateral to the lesioned side and total striatal DA depletion on the lesioned side. This injection also caused decrease in striatal serotonin (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA) levels. DA depletion was associated with increases in 5-HIAA/5-HT ratios that were potentiated by the METH injection. Microarray analyses revealed changes (± 1.7-fold, p<0.025) in the expression of 67 genes on the lesioned side in comparison to the intact side of the saline-treated hemiparkinsonian animals. These include follistatin, neuromedin U, and tachykinin 2 which were up-regulated. METH administration caused increases in the expression of c-fos, Egr1, and Nor-1 on the intact side. On the DA-depleted side, METH administration also increased the expression of 61 genes including Pdgf-d and Cox-2. There were METH-induced changes in 16 genes that were common in the DA-innervated and DA-depleted sides. These include c-fos and Nor-1 which show greater changes on the normal DA side. Thus, the present study documents, for the first time, that METH mediated DA-independent changes in the levels of transcripts of several genes in the DA-denervated striatum. Our results also implicate 5-HT as a potential player in these METH-induced alterations in gene expression because the METH injection also caused significant increases in 5-HIAA/5-HT ratios on the DA-depleted side
Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19
IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19.
Objective To determine whether angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) initiation improves outcomes in patients hospitalized for COVID-19.
DESIGN, SETTING, AND PARTICIPANTS In an ongoing, adaptive platform randomized clinical trial, 721 critically ill and 58 non–critically ill hospitalized adults were randomized to receive an RAS inhibitor or control between March 16, 2021, and February 25, 2022, at 69 sites in 7 countries (final follow-up on June 1, 2022).
INTERVENTIONS Patients were randomized to receive open-label initiation of an ACE inhibitor (n = 257), ARB (n = 248), ARB in combination with DMX-200 (a chemokine receptor-2 inhibitor; n = 10), or no RAS inhibitor (control; n = 264) for up to 10 days.
MAIN OUTCOMES AND MEASURES The primary outcome was organ support–free days, a composite of hospital survival and days alive without cardiovascular or respiratory organ support through 21 days. The primary analysis was a bayesian cumulative logistic model. Odds ratios (ORs) greater than 1 represent improved outcomes.
RESULTS On February 25, 2022, enrollment was discontinued due to safety concerns. Among 679 critically ill patients with available primary outcome data, the median age was 56 years and 239 participants (35.2%) were women. Median (IQR) organ support–free days among critically ill patients was 10 (–1 to 16) in the ACE inhibitor group (n = 231), 8 (–1 to 17) in the ARB group (n = 217), and 12 (0 to 17) in the control group (n = 231) (median adjusted odds ratios of 0.77 [95% bayesian credible interval, 0.58-1.06] for improvement for ACE inhibitor and 0.76 [95% credible interval, 0.56-1.05] for ARB compared with control). The posterior probabilities that ACE inhibitors and ARBs worsened organ support–free days compared with control were 94.9% and 95.4%, respectively. Hospital survival occurred in 166 of 231 critically ill participants (71.9%) in the ACE inhibitor group, 152 of 217 (70.0%) in the ARB group, and 182 of 231 (78.8%) in the control group (posterior probabilities that ACE inhibitor and ARB worsened hospital survival compared with control were 95.3% and 98.1%, respectively).
CONCLUSIONS AND RELEVANCE In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes.
TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT0273570
Synthesis of Chiral Aziridines Through Decarboxylative Generation of Sulfur Ylides and Their Reaction with Chiral Sulfinyl Imines
Antifungal Activities of some Phenolics and Related Compounds to three Fungal Plant Pathogens
Pression intracanalaire fémorale distale après mise en place de bouchons à ciment : etude in vitro
The use of Spanish by a monolingual kindergarten teacher to support English language learners
© 2015 Taylor & Francis. This article reports on a case study of a kindergarten, monolingual teacher and how she used Spanish, the home language of her Latino/a students who are English language learners (ELLs), in the classroom. The article focuses on how the teacher develops and uses her emerging knowledge of Spanish to scaffold students\u27 learning, specifically when emphasizing instruction, reinforcing key concepts, checking comprehension, managing the classroom, relating to students and providing encouragement. This study provides evidence that monolingual teachers can develop skills to use students\u27 home languages as an effective literacy teaching tool